PBYI

Q: What is the price of Puma Biotechnology (PBYI) today?

The price of Puma Biotechnology (PBYI) today is R$ 28,08, with a variation of 95.47% compared to the last year. The price of Puma Biotechnology (PBYI) started the year trading around R$ 16,53 and today it is at R$ 28,08. Follow the real-time price chart, the historical price of Puma Biotechnology (PBYI), and stock data from Ibovespa and international markets.

Q: When does Puma Biotechnology (PBYI) pay dividends?

Puma Biotechnology (PBYI) did not distribute dividends in the last year.

Q: Puma Biotechnology (PBYI) is it worth it?

Currently, Puma Biotechnology (PBYI) is priced at R$ 28,08, with a P/E of 5,42%, representing a deviation of 19.008,52% from its historical average P/E. In the last year, the stock showed a variation of 95.47% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 95,47%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Puma Biotechnology (PBYI)?

Investing in shares of Puma Biotechnology (PBYI) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Puma Biotechnology (PBYI) yield today?

The yield of Puma Biotechnology (PBYI) was 57,93% in the last month, 95,47% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of Puma Biotechnology (PBYI) today, the total investment would be based on the current price of R$ 28,08.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 5.487,94In 5 years: R$ 2.807,56In 10 years: 2.807,56It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Puma Biotechnology Inc.

Price

US$ 5,18

variation (12m)

95,47%

p/l

5,42

p/vp

2,51

DIVIDEND YIELD

0,00%

quote PBYI

BVMF

PBYI

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of PBYI

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

57,93%

3 months

53,71%

1 year

95,47%

2 years

39,62%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

57,93%

3 months

52,94%

1 year

85,73%

2 years

27,27%

5 years

0,00%

10 years

0,00%

Indicators PBYI

check out the fundamentals of Puma Biotechnology shares

P/L

5,42

Sector: -3,27 Industry: -3,27

P/SALES (PSR)

1,10

Sector: -3,77 Industry: -3,77

P/VP

2,51

Sector: 1,74 Industry: 1,74

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

24,86%

Sector: -63,50% Industry: -63,50%

ROE

46,27%

Sector: -67,23% Industry: -67,23%

ROIC

21,62%

Sector: -2.087,74% Industry: -2.087,74%

Net Margin

20,35%

Sector: -43,34% Industry: -43,34%

GROSS MARGIN

72,33%

Sector: 40,50% Industry: 40,50%

OPERATING MARGIN

19,35%

Sector: -43,21% Industry: -43,21%

P/EBITDA

4,15

Sector: -3,13 Industry: -3,13

P/EBIT

5,05

Sector: -3,41 Industry: -3,41

P/ASSETS

1,35

Sector: 1,29 Industry: 1,29

VPA

2,09

Sector: 1,80 Industry: 1,80

LPA

0,97

Sector: -2,09 Industry: -2,09

EQUITY / ASSETS

0,54

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

1,13%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

0,00%

Sector: - Industry: -

FAIR PRICE OF Puma Biotechnology ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 5,18

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

30,38%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

PBYI indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
JNJ	19,04	5,50	28,88%	2,80%	US$ 431,37 B	25,00%
PFE	13,45	1,62	12,08%	6,68%	US$ 144,63 B	16,84%
ABBV	79,66	228,58	286,94%	3,38%	US$ 334,19 B	7,31%
NVO	15,51	9,75	62,86%	2,83%	US$ 253,39 B	35,63%
MRK	13,05	4,36	33,44%	3,75%	US$ 214,13 B	25,79%
BMY	19,31	5,58	28,87%	5,13%	US$ 97,52 B	10,58%
GILD	22,64	7,29	32,21%	2,72%	US$ 142,89 B	21,87%
AZN	30,26	5,60	18,51%	1,91%	US$ 251,01 B	14,68%
ZTS	26,68	14,00	52,48%	1,19%	US$ 69,70 B	27,83%
HALO	15,59	26,12	167,47%	0,00%	US$ 8,69 B	47,28%
REGN	13,88	2,07	14,89%	0,30%	US$ 61,90 B	31,37%
AMGN	23,87	21,27	89,11%	3,15%	US$ 158,02 B	18,96%
VRTX	27,92	5,91	21,18%	0,00%	US$ 101,55 B	31,86%
ADMA	20,53	10,77	52,45%	0,00%	US$ 4,29 B	44,06%
MCK	27,24	-99,86	-366,63%	0,41%	US$ 86,18 B	0,84%
BIIB	13,38	1,16	8,68%	0,00%	US$ 20,48 B	15,31%
CAH	22,58	-13,38	-59,26%	1,37%	US$ 35,25 B	0,70%

comparison of PBYI with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history PBYI dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Puma Biotechnology

Puma Biotechnology Inc.

Average user rating I10

3.0 (0 people)

Estados Unidos

18 years

Foundation: 2007

2012

Year of debut on the stock exchange - 13 years

196

Employees

The Company Puma Biotechnology Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 262,50 Milhões, having a net worth of $ 104,72 Milhões.

With a total of 196 employees, the company is listed in the sector of Cuidados de saúde and categorized in industry of Biotecnologia.

In the last 12 months the Company had a revenue of $ 238,07 Milhões, which generated a profit in the amount of $ 48,45 Milhões.

As for its main indicators, the Company has a P/E ratio of 5,42, a P/B ratio of 2,51 and in the last 12 months the Company did not pay dividends.

The Company is traded through the ticker PBYI.

Market value

US$ 262,50 Milhões

Net worth

US$ 104,72 Milhões

US$ 104.720.000,00

Assets

US$ 194,92 Milhões

US$ 194.920.000,00

Total Number of Shares

50,00 Milhões

50.000.000

Average Daily Trading Volume

US$ 556,48 Thousand

US$ 556.475,16

Sector

Cuidados de saúde

Industry

Biotecnologia

PBYI

PBYI revenue and profits

PBYI results

DRAG THE FRAME TO SEE MORE DATA

PBYI cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12 M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12 M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12 M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12 M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12 M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12 M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12 M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

Common Questions

What is the price of Puma Biotechnology (PBYI) today?

The price of Puma Biotechnology (PBYI) today is R$ 28,08, with a variation of 95.47% compared to the last year. The price of Puma Biotechnology (PBYI) started the year trading around R$ 16,53 and today it is at R$ 28,08. Follow the real-time price chart, the historical price of Puma Biotechnology (PBYI), and stock data from Ibovespa and international markets.

When does Puma Biotechnology (PBYI) pay dividends?

Puma Biotechnology (PBYI) did not distribute dividends in the last year.

Puma Biotechnology (PBYI) is it worth it?

Currently, Puma Biotechnology (PBYI) is priced at R$ 28,08, with a P/E of 5,42%, representing a deviation of 19.008,52% from its historical average P/E. In the last year, the stock showed a variation of 95.47% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 95,47%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Puma Biotechnology (PBYI)?

Investing in shares of Puma Biotechnology (PBYI) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Puma Biotechnology (PBYI) yield today?

The yield of Puma Biotechnology (PBYI) was 57,93% in the last month, 95,47% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of Puma Biotechnology (PBYI) today, the total investment would be based on the current price of R$ 28,08.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 5.487,94
In 5 years: R$ 2.807,56
In 10 years: 2.807,56

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

PBYI

Puma Biotechnology Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of PBYI

check out the fundamentals of Puma Biotechnology shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Puma Biotechnology

Puma Biotechnology Inc.

Estados Unidos

18 years

2012

196

PROFIT X PRICE PBYI

PBYI results

PBYI cash flow

evolution of assets - PBYI

PBYI balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80